retatrutide vs. tirzepatide vs #tirzepatide at a glance… #onthepen Retatrutide for weight loss: Study

The most frequent adverse events were dry mouth (46%), hypertension (43%), diarrhea (38%), fatigue (38%), increased aspartate aminotransferase level (35%), nausea (35%), and constipation (35%)

This is an important consideration, as headaches, musculoskeletal discomfort, and other common ailments requiring analgesia may occur during weight loss treatment

doi: 10.1111/bph.12490 55 SamsonSLSathyanarayanaPJogiMGonzalezEVGutierrezAKrishnamurthyRet al

Whats the Real Problem

In the SURMOUNT-5 trial, tirzepatide produced an average weight reduction of 20.2% (about 50 lbs) over 72 weeks, compared with 13.7% (about 33 lbs) for injectable semaglutide

Women should discuss their individual circumstances with their healthcare provider to develop a safe, effective weight management plan that considers both maternal health goals and infant nutrition needs